Trial Profile
Phase 1 study of Core Protein Allosteric Modulators in Hepatitis B patients
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2016
Price :
$35
*
At a glance
- Drugs Viral core protein modulators (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 15 Apr 2016 New trial record
- 13 Apr 2016 According to Assembly Biosciences media release, company plans to start this trial in 2H16.